Osteopenia
Osteopenia, or "low bone mass," is a condition characterized by decreased bone mineral density that weakens bones and increases the risk of fractures, but is not as severe as osteoporosis. It often occurs with aging and can be influenced by lifestyle, genetics, medication, or other health conditions; it typically does not cause symptoms or pain.
Health Outcomes
- Achieved Sufficient 25-Hydroxyvitamin D Level
- Decreased Hydroxyapatite Integrity
- Delayed Osteoporosis Progression
- Improved Acceptability of Dairy Products
- Improved Alveolar Bone Density
- Improved Bench Press Performance
- Improved Bone Composition
- Improved Bone Defect Healing
- Improved Bone Defect Repair
- Improved Bone Density Marker
- Improved Bone Formation
- Improved Bone Fracture Healing
- Improved Bone Mass Density
- Improved Bone Metabolism
- Improved Bone Microstructure
- Improved Bone Mineral Content
- Improved Bone Mineral Density
- Improved Bone Preservation
- Improved Bone Regeneration
- Improved Bone Strength
- Improved Bone Turnover Marker
- Improved Bone Volume
- Improved Calcium Absorption
- Improved Calcium Retention
- Improved Calcium and Phosphorus Metabolism
- Improved Countermovement Jump Performance
- Improved Deadlift Performance
- Improved Femoral Neck Bone Mineral Density
- Improved Hip Fracture Healing
- Improved Hip Joint Bone Mineral Density
- Improved Jumping Power
- Improved Leg Press One Repetition Maximum
- Improved Lower-Body Muscular Strength
- Improved Lumbar Bone Mineral Density
- Improved Magnesium Bioaccessibility
- Improved Maximal Muscular Strength
- Improved Mechanical Properties
- Improved Nutrient Retention
- Improved Osseointegration
- Improved Osteoporosis Treatment
- Improved Resistance Exercise Performance
- Improved Resistance Training Performance
- Improved Sarcopenia
- Improved Strength Performance
- Improved Total Hip Bone Mineral Density
- Improved Total Volumetric Bone Mineral Density
- Improved Trabecular Number
- Improved Vitamin D Levels
- Improved Vitamin K Status
- Increased Bone-Specific Alkaline Phosphatase Level
- Increased Carboxylated Osteocalcin Ratio
- Increased Gamma-Carboxylated Osteocalcin Levels
- Increased Hip Fracture Risk
- Increased Osteocalcin Level
- Increased P1NP Level
- Increased Plasma Vitamin K Levels
- Inhibited Decline in Bone Mineral Density
- Maintained Cross-Linked Telopeptide of Type 1 Collagen Level
- Osteoporosis Prevention
- Osteoporosis Treatment Strategy
- Preserved Lumbar Bone Mineral Density
- Prevented Bone Loss
- Prevented Sarcopenia
- Reduced Aging Effects
- Reduced Alveolar Bone Absorption
- Reduced Beta-CrossLap
- Reduced Biochemical Parameter Level
- Reduced Bone Density Loss
- Reduced Bone Fracture
- Reduced Bone Loss
- Reduced Bone Mass
- Reduced Bone Mineral Density
- Reduced Bone Resorption Marker
- Reduced Bone Turnover
- Reduced Bone-Specific Alkaline Phosphatase Level
- Reduced C-terminal Telopeptide Level
- Reduced Collagen Density
- Reduced Fall Number
- Reduced Fall Occurrence
- Reduced Fracture Incidence
- Reduced Fracture Risk
- Reduced Non-vertebral Fracture
- Reduced Nonvertebral Fracture
- Reduced P1NP Level
- Reduced Procollagen Type 1 N Propeptide Level
- Reduced Risk of Insufficient 25-Hydroxyvitamin D Level
- Reduced Risk of Low Bone Mineral Density
- Reduced Risk of Osteoporotic Fractures
- Reduced Shell Breaking Strength
- Reduced Total Clinical Fracture
- Reduced Undercarboxylated-to-Carboxylated Osteocalcin Ratio
- Reduced Urine Deoxypyridinoline Levels
- Reduced Vitamin D Deficiency
- Reduced Vitamin D Deficiency Prevalence
- Reduced Vitamin D Level
- Stable Lumbar Bone Mineral Density
- Strengthened Musculoskeletal System